If a patient exhibits signs of hypersensitivity to an IV medication, what should be the first action?

When a patient exhibits signs of hypersensitivity to an IV medication, the immediate priority is to ensure the safety and well-being of the patient. Stopping the infusion is crucial because continuing the administration of the medication could exacerbate the hypersensitivity reaction, leading to more severe outcomes.

After stopping the infusion, assessing the patient allows the healthcare provider or assisting personnel to identify the severity of the reaction and provide appropriate care. Notifying the healthcare provider is also vital, as they may need to take further action, including determining alternative treatments or interventions.

This approach prioritizes patient safety by promptly addressing the hypersensitivity reaction rather than delaying intervention while potentially harmful medication continues to circulate in the patient's system.